The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Zhen GeUsman BaberBimmer E P M ClaessenSerdar FarhanJaya ChandrasekharShawn X LiSamantha SartoriAnnapoorna S KiniSunil V RaoSandra WeissTimothy D HenryBirgit VogelSabato SorrentinoMichela FaggioniSamir R KapadiaBrent MuhlesteinCraig StraussCatalin TomaAnthony DeFrancoMark B EffronStuart KellerBrian A BakerStuart PocockGeorge D DangasRoxana MehranPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
In a contemporary practice setting in the United States, GDMT was utilized in just over two-thirds of AMI patients undergoing PCI. Predictors of GDMT prescription at discharge included STEMI, BMI and absence of hypertension, CKD, anemia or prior PCI. Use of GDMT was associated with significantly lower risk of 1-year MACE and mortality.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- patients undergoing
- coronary artery disease
- antiplatelet therapy
- acute coronary syndrome
- chronic kidney disease
- healthcare
- risk factors
- blood pressure
- left ventricular
- coronary artery bypass grafting
- cardiovascular events
- primary care
- body mass index
- atrial fibrillation
- quality improvement
- coronary artery bypass
- heart failure
- physical activity
- metabolic syndrome
- cardiovascular disease
- adipose tissue